Xenex Disinfection Services, a San Antonio-based developer of automated environmental disinfection technology for healthcare facilities, secured $25m in funding.
Backers included new participation from Brandon Point Industries Limited (Brandon Point) and existing investors Battery Ventures, Targeted Technology Fund II and RK Ventures.
The company intends to use the funds for product development, international expansion and increasing U.S. sales force.
Led by Morris Miller, CEO, Xenex has developed patented pulsed xenon Full Spectrum™ ultraviolet (UV) disinfection technology proven to destroy the viruses, bacteria, mold, fungus and bacterial spores in healthcare facilities that cause infections. With a five-minute disinfection cycle, the robot disinfects 30-62 hospital rooms per day (according to Xenex customers), including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas.
More than 250 hospitals, Veterans Affairs and DoD facilities in the U.S. are using Xenex robots, which are also in use in skilled nursing facilities, ambulatory surgery centers and long term acute care facilities.
FinSMEs
27/01/2015